EP Wealth Advisors
BNTX icon

EP Wealth Advisors’s BioNTech BNTX Stock Holding History

EP Wealth Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$255K Sell
2,596
-10,127
-80% -$983K ﹤0.01% 1361
2026
Q2 		$1.18M Buy
12,723
+8,389
+194% +$789K ﹤0.01% 707
2026
Q1 		$385K Buy
+4,334
New +$445K ﹤0.01% 1026

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Davern Capital Partners
Davern Capital Partners Ny, New York $514M AUM 16.9% 1-Year Est. Return
GSK plc
GSK plc London $497M AUM 35.1% 1-Year Est. Return

EP Wealth Advisors's BNTX Position: Q3 2026 in Review

EP Wealth Advisors reduced its BioNTech (BNTX) stake by 80% in Q3 2026, selling an estimated $983K and leaving 2,596 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #1361.

EP Wealth Advisors first reported a position in BNTX in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.18M in Q2 2026. 223 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.

  • EP Wealth Advisors held 2,596 shares of BioNTech worth $255K as of Q3 2026.
  • EP Wealth Advisors sold 10,127 BioNTech shares in Q3 2026, an estimated $983K.
  • BioNTech made up ﹤0.01% of EP Wealth Advisors's portfolio in Q3 2026, its #1361 holding.
  • EP Wealth Advisors first reported a position in BioNTech in Q1 2026 and has held it in 3 quarters since.
  • EP Wealth Advisors's BioNTech position peaked at $1.18M in Q2 2026.
  • 223 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.

Based on EP Wealth Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.